Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 12, 2014, Pages 3248-3258

  Perrone, Rosalba ^a   Butovskaya, Elena ^a   Daelemans, Dirk ^b   Palù, Giorgio ^a   Pannecouque, Christophe ^b   Richter, Sara N ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral activity; G quadruplex RNA; Nucleic acid secondary conformation; Small molecule; Time of addition

Indexed keywords

ACRIDINE DERIVATIVE; GUANINE QUADRUPLEX; RNA DIRECTED DNA POLYMERASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BRACO19; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; ULTRAVIOLET SPECTROSCOPY; VIRUS ATTACHMENT; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; DRUG EFFECTS; IC50; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; PHYSIOLOGY; PROVIRUS; REVERSE TRANSCRIPTION;

ACRIDINES; ANTI-HIV AGENTS; G-QUADRUPLEXES; HIV-1; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PROVIRUSES; REVERSE TRANSCRIPTION; RNA, VIRAL;

EID: 84934311720     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku280     Document Type: Article

References (51)

1. Burge S, Parkinson GN, Hazel P et al. Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res 2006; 34: 5402-15.
2. Hazel P, Huppert J, Balasubramanian S et al. Loop-length-dependent folding of G-quadruplexes. J Am Chem Soc 2004; 126: 16405-15.
3. Rachwal PA, Findlow IS, Werner JM et al. Intramolecular DNA quadruplexes with different arrangements of short and long loops. Nucleic Acids Res 2007; 35: 4214-22.
4. Zhang DH, Fujimoto T, Saxena S et al. Monomorphic RNA G-quadruplex and polymorphic DNA G-quadruplex structures responding to cellular environmental factors. Biochemistry 2010; 49: 4554-63.
5. Zhang AY, Bugaut A, Balasubramanian S. A sequence-independent analysis of the loop length dependence of intramolecular RNA G-quadruplex stability and topology. Biochemistry 2011; 50: 7251-8.
6. Sacca B, Lacroix L, Mergny JL. The effect of chemical modifications on the thermal stability of different G-quadruplex-forming oligonucleotides. Nucleic Acids Res 2005; 33: 1182-92.
7. Joachimi A, Benz A, Hartig JS. A comparison of DNA and RNA quadruplex structures and stabilities. Bioorg Med Chem 2009; 17: 6811-5.
8. Huppert JL, Balasubramanian S. G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res 2007; 35: 406-13.
9. Balasubramanian S, Hurley LH, Neidle S. Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev Drug Discov 2011; 10: 261-75.
10. Millevoi S, Moine H, Vagner S. G-quadruplexes in RNA biology. Wiley Interdiscip Rev RNA 2012; 3: 495-507.
11. Arora A, Dutkiewicz M, Scaria V et al. Inhibition of translation in living eukaryotic cells by an RNA G-quadruplex motif. RNA 2008; 14: 1290-6.
12. Kumari S, Bugaut A, Huppert JL et al. An RNA G-quadruplex in the 5' UTR of the NRAS proto-oncogene modulates translation. Nat Chem Biol 2007; 3: 218-21.
13. Morris MJ, Basu S. An unusually stable G-quadruplex within the 5'-UTR of the MT3 matrix metalloproteinase mRNA represses translation in eukaryotic cells. Biochemistry 2009; 48: 5313-9.
14. Morris MJ, Negishi Y, Pazsint C et al. An RNA G-quadruplex is essential for cap-independent translation initiation in human VEGF IRES. J Am Chem Soc 2010; 132: 17831-9.
15. Bugaut A, Balasubramanian S. 5'-UTR RNA G-quadruplexes: translation regulation and targeting. Nucleic Acids Res 2012; 40: 4727-41.
16. Huppert JL, Bugaut A, Kumari S et al. G-quadruplexes: the beginning and end of UTRs. Nucleic Acids Res 2008; 36: 6260-8.
17. Biffi G, Tannahill D, McCafferty J et al. Quantitative visualization of DNA G-quadruplex structures in human cells. Nat Chem 2013; 5: 182-6.
18. Biffi G, Di Antonio M, Tannahill D et al. Visualization and selective chemical targeting of RNA G-quadruplex structures in the cytoplasm of human cells. Nat Chem 2014; 6: 75-80.
19. Read M, Harrison RJ, Romagnoli B et al. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Proc Natl Acad Sci USA 2001; 98: 4844-9.
20. White EW, Tanious F, Ismail MA et al. Structure-specific recognition of quadruplex DNA by organic cations: influence of shape, substituents and charge. Biophys Chem 2007; 126: 140-53.
21. Harrison RJ, Cuesta J, Chessari G et al. Trisubstituted acridine derivatives as potent and selective telomerase inhibitors. J Med Chem 2003; 46: 4463-76.
22. Gowan SM, Harrison JR, Patterson L et al. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. Mol Pharmacol 2002; 61: 1154-62.
23. Burger AM, Dai F, Schultes CM et al. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res 2005; 65: 1489-96.
24. Beaume N, Pathak R, Yadav VK et al. Genome-wide study predicts promoter-G4 DNA motifs regulate selective functions in bacteria: radioresistance of D. radiodurans involves G4 DNA-mediated regulation. Nucleic Acids Res 2013; 41: 76-89.
25. Rawal P, Kummarasetti VB, Ravindran J et al. Genome-wide prediction of G4 DNA as regulatory motifs: role in Escherichia coli global regulation. Genome Res 2006; 16: 644-55.
26. Wieland M, Hartig JS. Investigation of mRNA quadruplex formation in Escherichia coli. Nat Protoc 2009; 4: 1632-40.
27. Norseen J, Johnson FB, Lieberman PM. Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment. J Virol 2009; 83: 10336-46.
28. Tluckova K, Marusic M, Tothova P et al. Human papillomavirus G-quadruplexes. Biochemistry 2013; 52: 7207-16.
29. Sundquist WI, Heaphy S. Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA. Proc Natl Acad Sci USA 1993; 90: 3393-7.
30. Marquet R, Paillart JC, Skripkin E et al. Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site. Nucleic Acids Res 1994; 22: 145-51.
31. Piekna-Przybylska D, Sharma G, Bambara RA. Mechanism of HIV-1 RNA dimerization in the central region of the genome and significance for viral evolution. J Biol Chem 2013; 288: 24140-50.
32. ShenW, Gao L, Balakrishnan M et al. A recombination hot spot in HIV-1 contains guanosine runs that can form a G-quartet structure and promote strand transfer in vitro. J Biol Chem 2009; 284: 33883-93.
33. Lyonnais S, Gorelick RJ, Mergny JL et al. G-quartets direct assembly of HIV-1 nucleocapsid protein along single-stranded DNA. Nucleic Acids Res 2003; 31: 5754-63.
34. Perrone R, Nadai M, Frasson I et al. A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter. J Med Chem 2013; 56: 6521-30.
35. Perrone R, Nadai M, Poe JA et al. Formation of a unique cluster of G-quadruplex structures in the HIV-1 Nef coding region: implications for antiviral activity. PLoS One 2013; 8: e73121.
36. Horwitz JP, Chua J, Noel M et al. Nucleosides. IV. 1-(2-deoxy-b-Dlyxofuranosyl)-5-iodouracil. J Med Chem 1964; 7: 385-6.
37. Pannecouque C, Daelemans D, De Clercq E. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later. Nat Protoc 2008; 3: 427-34.
38. Daelemans D, Pauwels R, De Clercq E et al. A time-of-drug addition approach to target identification of antiviral compounds. Nat Protoc 2011; 6: 925-33.
39. Gunaratnam M, Greciano O, Martins C et al. Mechanism of acridinebased telomerase inhibition and telomere shortening. Biochem Pharmacol 2007; 74: 679-89.
40. Incles CM, Schultes CM, Kempski H et al. A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. Mol Cancer Ther 2004; 3: 1201-6.
41. Vercruysse T, Basta B, Dehaen W et al. A phenyl-thiadiazolylideneamine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions. Retrovirology 2012; 9: 95.
42. Wilkinson RA, Pincus SH, Shepard JB et al. Novel compounds containing multiple guanide groups that bind the HIV coreceptor CXCR4. Antimicrob Agents Chemother 2011; 55: 255-63.
43. Faudale M, Cogoi S, Xodo LE. Photoactivated cationic alkyl-substituted porphyrin binding to g4-RNA in the 5'-UTR of KRAS oncogene represses translation. Chem Commun (Camb) 2012; 48: 874-6.
44. Harrison RJ, Reszka AP, Haider SM et al. Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. Bioorg Med Chem Lett 2004; 14: 5845-9.
45. Incles CM, Schultes CM, Kelland LR et al. Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor. Mol Pharmacol 2003; 64: 1101-8.
46. CampbellNH, ParkinsonGN, ReszkaAPet al. Structural basis of DNA quadruplex recognition by an acridine drug. J Am Chem Soc 2008; 130: 6722-4.
47. Campbell NH, Patel M, Tofa AB et al. Selectivity in ligand recognition of G-quadruplex loops. Biochemistry 2009; 48: 1675-80.
48. Bertrand H, Granzhan A, Monchaud D et al. Recognition of G-quadruplex DNA by triangular star-shaped compounds: with or without side chains? Chemistry 2011; 17: 4529-39.
49. Di Antonio M, Biffi G, Mariani A et al. Selective RNA versus DNA G-quadruplex targeting by in situ click chemistry. Angew Chem Int Ed Engl 2012; 51: 11073-8.
50. Collie G, Reszka AP, Haider SM et al. Selectivity in small molecule binding to human telomeric RNA and DNA quadruplexes. Chem Commun (Camb) 2009; 7482-4.
51. Collie GW, Haider SM, Neidle S et al. A crystallographic and modelling study of a human telomeric RNA (TERRA) quadruplex. Nucleic Acids Res 2010; 38: 5569-80.